Skip to content
SlushFund

Companies · USAspending parent record

KAIVA STRATEGIES, LLC

No confirmed stock ticker. 1 recipient record grouped under this USAspending parent (UEI HCWKVFGBPA64).

Non-competed awards
$21.3M

obligated to date on 9 non-competed awards of $1M+ signed FY2024–26

USAspendingas of Oct 3

Obligated to date, not spending in a year. Selected awards only (rule r5-v1): not this company's not-competed share.

Awards in our records
11

9 non-competed ($1M+) · 2 other ($10M+)

USAspendingas of Oct 3
Largest award
$16.0M

obligated to date: 75F40126F19026, Department of Health and Human Services, signed FY2026

USAspendingas of Oct 3
Member trades
No ticker

No confirmed stock ticker, so no member trades are matched to this company.

House Clerk + Senate eFDas of Oct 4
Source: USAspending.gov · SEC EDGAR company tickers · House Clerk PTRs · Senate eFDCoverage: Contract awards FY2024–FY2026 · Ticker links FY2024–26 recipients · House 2021–2026 · Senate 2024–2026Updated: Methodology →

Federal contract awards in our records

Each row is one prime contract award on USAspending.gov; “USAspending” opens its official page.

What this table covers: every award signed in FY2024–26 that the agency coded “not competed” and that is $1 million or more, plus any award of $10 million or more (rule r5-v1). Smaller competed awards are not in it, so it is not this company’s total federal business and it cannot show a not-competed share. “Obligated to date” is the total committed on the award so far, including later modifications (USAspending, as of Oct 3, 2026), not the amount at any earlier date.

Awards by fiscal year signed (obligated to date, not spending in the year)
Signed inNon-competed awardsObligated to dateOther awards $10M+Obligated to date
FY20248$18.4MNone in this set—
FY2025None in this set—1$15.5M
FY2026incomplete1$2.9M1$16.0M

FY2026 is incomplete: the Department of Defense reports contract actions 90 days late, and older awards keep growing through modifications, so these amounts will rise. Source: USAspending.gov, as of Oct 3, 2026.

FY2024–26 awards to KAIVA STRATEGIES, LLC, largest first (obligated to date)
Source
75F40126F19026Order under IDV 75F40123D000212-YEAR, LABOR HOUR (LH) TYPE TASK ORDER FOR FOOD AND DRUG ADMINISTRATION (FDA) OFFICE OF FINANCE, BUDGET, AND ACQUISITIONS (OFBA) BUDGET AND ACQUISITION LIAISON SUPPORTDepartment of Health and Human ServicesSep 21, 2026FY2026Full and open competition after exclusion of sources$15,999,631USAspending
75F40125F19016Order under IDV 75F40123D000211-YEAR, LABOR HOUR (LH) TYPE TASK ORDER FOR U.S. FOOD AND DRUG ADMINISTRATION (FDA), OFFICE OF FINANCE, BUDGET, AND ACQUISITIONS (OFBA) FOR BUDGET AND ACQUISITION LIAISON SUPPORTDepartment of Health and Human ServicesSep 30, 2025FY2025Full and open competition after exclusion of sources$15,503,505USAspending
75F40124C00092DIRECT 8(A) AWARD OF 3-YEAR, TIME & MATERIALS TYPE CONTRACT TO KAIVA TO PROVIDE TPLC ADVISORY PROGRAM (TAP) FOR THE CDRHDepartment of Health and Human ServicesSep 10, 2024FY2024Not competedOnly one source-other (FAR 6.302-1 other)$4,246,242USAspending
75D30124C18523HELP DESK AND USER SUPPORTDepartment of Health and Human ServicesJun 6, 2024FY2024Not competed under SAPAuthorized by statute (FAR 6.302-5(a)(2)(i))$3,496,104USAspending
75F40124C00055CDRH PROFESSIONAL AND TECHNICAL SUPPORT SERVICESDepartment of Health and Human ServicesJul 18, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$3,297,142USAspending
75F40126F19009Order under IDV 75F40122D000183-YEAR, LABOR-HOUR (LH) TYPE TASK ORDER FOR MEDICAL WRITERS SUPPORT SERVICES (POST-MARKET SURVEILLANCE) TO SUPPORT THE U.S. FOOD AND DRUG ADMINISTRATION (FDA), CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), OFFICE OF BIOSTATISTICS AND PHARMACOVDepartment of Health and Human ServicesSep 11, 2026FY2026Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$2,855,874USAspending
75F40124C00053TO PROVIDE THE CDRH?S OFFICE OF THE CENTER DIRECTOR (OCD) AND THE CVM WITH THE PROFESSIONAL SUPPORT SERVICES OF A SME IX TO PROVIDE SUPPORT RELATED TO THE MDUFA, ADUFA, AND AGDUFA. THE SME IX SHALL SUPPORT THE EXISTING USER FEE ACTS AND ASSIST FDA LEDepartment of Health and Human ServicesMay 6, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$1,945,474USAspending
75F40124C00097DIRECT 8(A) AWARD OF (1) 12-MONTH BASE PERIOD AND (4) 12-MONTH OPTION PERIODS, TIME & MATERIALS (T&M) TYPE CONTRACT TO KAIVA STRATEGIES, LLC FOR PROFESSIONAL SERVICES TO SUPPORT FDA OFFICE OF WOMEN'S HEALTH SCIENCE RELATED ACTIVITIES, OFDepartment of Health and Human ServicesAug 27, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$1,867,925USAspending
75F40124F19008Order under IDV 75F40122D00018SCIENTIFIC WRITING SUPPORTDepartment of Health and Human ServicesJul 9, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$1,358,022USAspending
75F40124F19007Order under IDV 75F40122D00018MEDICAL WRITER SUPPORTDepartment of Health and Human ServicesMay 10, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$1,185,326USAspending
75F40124C00074THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) HEREBY INTENDS TO PROCURE PROJECT MANAGEMENT SUPPORT SERVICES THROUGH A DIRECT 8(A) AWARD OF A SINGLE, LABOR-HOUR (LH) TYPE CONTRACT CONSISTING OF ONE (1), 12-MONTH BASE PERIOD AND NO OPTION PERIODS.Department of Health and Human ServicesJul 24, 2024FY2024Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))$1,030,505USAspending

FY2024–26 awards to KAIVA STRATEGIES, LLC, largest first (obligated to date)

  • 75F40126F19026Order under IDV 75F40123D000212-YEAR, LABOR HOUR (LH) TYPE TASK ORDER FOR FOOD AND DRUG ADMINISTRATION (FDA) OFFICE OF FINANCE, BUDGET, AND ACQUISITIONS (OFBA) BUDGET AND ACQUISITION LIAISON SUPPORT
    Signed
    Sep 21, 2026FY2026
    Competition
    Full and open competition after exclusion of sources
    Obligated to date
    $15,999,631
  • 75F40125F19016Order under IDV 75F40123D000211-YEAR, LABOR HOUR (LH) TYPE TASK ORDER FOR U.S. FOOD AND DRUG ADMINISTRATION (FDA), OFFICE OF FINANCE, BUDGET, AND ACQUISITIONS (OFBA) FOR BUDGET AND ACQUISITION LIAISON SUPPORT
    Signed
    Sep 30, 2025FY2025
    Competition
    Full and open competition after exclusion of sources
    Obligated to date
    $15,503,505
  • 75F40124C00092DIRECT 8(A) AWARD OF 3-YEAR, TIME & MATERIALS TYPE CONTRACT TO KAIVA TO PROVIDE TPLC ADVISORY PROGRAM (TAP) FOR THE CDRH
    Signed
    Sep 10, 2024FY2024
    Competition
    Not competedOnly one source-other (FAR 6.302-1 other)
    Obligated to date
    $4,246,242
  • 75D30124C18523HELP DESK AND USER SUPPORT
    Signed
    Jun 6, 2024FY2024
    Competition
    Not competed under SAPAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $3,496,104
  • 75F40124C00055CDRH PROFESSIONAL AND TECHNICAL SUPPORT SERVICES
    Signed
    Jul 18, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $3,297,142
  • 75F40126F19009Order under IDV 75F40122D000183-YEAR, LABOR-HOUR (LH) TYPE TASK ORDER FOR MEDICAL WRITERS SUPPORT SERVICES (POST-MARKET SURVEILLANCE) TO SUPPORT THE U.S. FOOD AND DRUG ADMINISTRATION (FDA), CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), OFFICE OF BIOSTATISTICS AND PHARMACOV
    Signed
    Sep 11, 2026FY2026
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $2,855,874
  • 75F40124C00053TO PROVIDE THE CDRH?S OFFICE OF THE CENTER DIRECTOR (OCD) AND THE CVM WITH THE PROFESSIONAL SUPPORT SERVICES OF A SME IX TO PROVIDE SUPPORT RELATED TO THE MDUFA, ADUFA, AND AGDUFA. THE SME IX SHALL SUPPORT THE EXISTING USER FEE ACTS AND ASSIST FDA LE
    Signed
    May 6, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $1,945,474
  • 75F40124C00097DIRECT 8(A) AWARD OF (1) 12-MONTH BASE PERIOD AND (4) 12-MONTH OPTION PERIODS, TIME & MATERIALS (T&M) TYPE CONTRACT TO KAIVA STRATEGIES, LLC FOR PROFESSIONAL SERVICES TO SUPPORT FDA OFFICE OF WOMEN'S HEALTH SCIENCE RELATED ACTIVITIES, OF
    Signed
    Aug 27, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $1,867,925
  • 75F40124F19008Order under IDV 75F40122D00018SCIENTIFIC WRITING SUPPORT
    Signed
    Jul 9, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $1,358,022
  • 75F40124F19007Order under IDV 75F40122D00018MEDICAL WRITER SUPPORT
    Signed
    May 10, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $1,185,326
  • 75F40124C00074THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) HEREBY INTENDS TO PROCURE PROJECT MANAGEMENT SUPPORT SERVICES THROUGH A DIRECT 8(A) AWARD OF A SINGLE, LABOR-HOUR (LH) TYPE CONTRACT CONSISTING OF ONE (1), 12-MONTH BASE PERIOD AND NO OPTION PERIODS.
    Signed
    Jul 24, 2024FY2024
    Competition
    Not available for competitionAuthorized by statute (FAR 6.302-5(a)(2)(i))
    Obligated to date
    $1,030,505
11 awards. Source: USAspending.gov award records.
Recipient records grouped under this company (1)

USAspending groups recipients by its parent-company field, which has known errors. Check that the recipients below belong to KAIVA STRATEGIES, LLC; the stock link below is made per recipient.

  • KAIVA STRATEGIES, LLC11 awards · 9 non-competed, $21.3M obligated to date

Stock ticker

Links between a federal contract recipient and an SEC-registered company, made by a written rule from SEC filings and USAspending records. Only confirmed links are shown.

No confirmed stock ticker: this may be a private company, a subsidiary awaiting review, or not matched to an SEC registrant.

Members of Congress who reported trading this stock

No confirmed stock ticker: this may be a private company, a subsidiary awaiting review, or not matched to an SEC registrant. Without a confirmed ticker, no trades are matched to this company.

Looking for agency-level shares? See non-competed share by agency.